- Home
- MNSB vs LUCD Comparison
MNSB vs LUCD Comparison
Compare MNSB & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | LUCD |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | United States | United States |
| Employees | 171 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.3M | 190.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNSB | LUCD |
|---|---|---|
| Price | $24.81 | $1.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 54.8K | ★ 802.3K |
| Earning Date | 04-20-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.62% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | $1.50 | $115.58 |
| Revenue Next Year | $3.77 | $130.54 |
| P/E Ratio | $12.64 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $17.86 | $0.95 |
| 52 Week High | $25.17 | $1.70 |
Technical Indicators
Market Signals| Indicator | MNSB | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 39.12 |
| Support Level | $20.84 | $1.02 |
| Resistance Level | $25.14 | $1.14 |
| Average True Range (ATR) | 0.71 | 0.09 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 66.67 | 8.65 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.